Learn More
PURPOSE To perform a detailed analysis of variables associated with late tissue effects of high-dose-rate (HDR) interstitial brachytherapy accelerated partial breast irradiation (APBI) in a large(More)
PURPOSE Multiple investigations have used the skin distance as a surrogate for the skin dose and have shown that distances <6 mm have been associated with late toxicity after MammoSite brachytherapy.(More)
PURPOSE To determine the associated toxicity, tolerance, and safety of partial-breast reirradiation. METHODS AND MATERIALS Eligibility criteria included in-breast recurrence occurring >1 year after(More)